Observational analysis shows high complete response rates with radiotherapy in primary cutaneous lymphomas, indicating effective disease control with manageable toxicity.
Key Points
Radiotherapy demonstrates high efficacy, achieving significant disease control with manageable toxicity for primary cutaneous lymphomas.
Electron beam therapy and superficial brachytherapy have shown complete response rates, particularly for localized cutaneous T-cell lymphomas and B-cell lymphomas.
Assessment using radiotherapy modalities, like low-dose radiotherapy, reduces skin toxicity while maintaining effective responses in cutaneous lymphomas.
Ongoing research emphasizes optimizing radiation strategies and exploring combinations with systemic therapies for aggressive lymphomas.